Dentistry during the COVID-19 Epidemic: An Italian Workflow for the Management of Dental Practice.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
11 05 2020
Historique:
received: 23 04 2020
revised: 05 05 2020
accepted: 08 05 2020
entrez: 15 5 2020
pubmed: 15 5 2020
medline: 20 5 2020
Statut: epublish

Résumé

The COVID-19 outbreak has raised concerns about infection control all over the world. Among health workers, dentists are particularly exposed to the COVID-19 infection risk. The aim of this paper is to present a workflow to manage dental procedures already in use at the Dental Unit of the University Hospital of Messina. The proposed workflow accounts for the many aspects of dental practitioners' risk in the COVID-19 era, and focuses on the assessment of patient risk level, a two-phase dental procedure management (remote and face-to-face), and the use of specific preventive measures. No cases of COVID-19 infection were detected among patients and staff of the dental unit in a two-month period of time while using this protocol. This workflow seems a promising and effective solution to manage dental procedures during the COVID-19 outbreak, and could be implemented in both public and private practices until the emergency is contained.

Identifiants

pubmed: 32403248
pii: ijerph17093325
doi: 10.3390/ijerph17093325
pmc: PMC7246688
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

JAMA. 2020 Mar 4;:
pubmed: 32129805
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Dent Res. 2020 Apr 17;:22034520920580
pubmed: 32302257
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Clin Oral Investig. 2020 Apr;24(4):1619-1621
pubmed: 32078048
JAMA. 2020 Feb 7;:
pubmed: 32031570
Microbiol Mol Biol Rev. 2013 Mar;77(1):144-56
pubmed: 23471620
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
J Infect. 2020 Apr 14;:
pubmed: 32298676
Dermatology. 2006;212 Suppl 1:119-23
pubmed: 16490989
CMAJ. 2020 Apr 14;192(15):E410
pubmed: 32392504
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046819
Infect Control Hosp Epidemiol. 2020 May;41(5):493-498
pubmed: 32131908
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
J Dent Res. 2020 May;99(5):481-487
pubmed: 32162995
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Int J Oral Sci. 2020 Mar 3;12(1):9
pubmed: 32127517
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
J Dent Res. 2020 Apr 9;:22034520918518
pubmed: 32271653
J Infect. 2020 May;80(5):e14-e17
pubmed: 32171867
Int J Environ Res Public Health. 2020 Mar 22;17(6):
pubmed: 32235685
Saudi Dent J. 2020 Apr 7;:
pubmed: 32292260
Clin Infect Dis. 2020 Feb 12;:
pubmed: 32047895
Lancet. 2020 Feb 22;395(10224):e39
pubmed: 32035510
Ann Intern Med. 2020 May 5;172(9):619-620
pubmed: 32160299
Oral Oncol. 2020 Jul;106:104659
pubmed: 32209313

Auteurs

Matteo Peditto (M)

Postgraduate School of Oral Surgery, Department of Biomedical, Dental Sciences and Morphofunctional Imaging, University of Messina, 98125 Messina, Italy.

Simone Scapellato (S)

Postgraduate School of Oral Surgery, Department of Biomedical, Dental Sciences and Morphofunctional Imaging, University of Messina, 98125 Messina, Italy.

Antonia Marcianò (A)

Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.

Paola Costa (P)

Postgraduate School of Oral Surgery, Department of Biomedical, Dental Sciences and Morphofunctional Imaging, University of Messina, 98125 Messina, Italy.

Giacomo Oteri (G)

Postgraduate School of Oral Surgery, Department of Biomedical, Dental Sciences and Morphofunctional Imaging, University of Messina, 98125 Messina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH